TransCode Therapeutics Q4 2024 Earnings Deep Losses Reflect PreRevenue Stage CTOS Q1 2026 Earnings EPS Misses Estimates as Company Navigates Operational Challenges RILYL Q1 2024 Earnings Preferred Stock Reports Negative EPS Amid Market Challenges Z Q1 2026 Earnings EPS Surges Past Estimates Amid Housing Market Uncertainty NVCR Q1 2026 Earnings WiderthanExpected Loss Despite Positive Stock Reaction HWM Q1 2026 Earnings EPS Surprises to the Upside as Aerospace Demand Remains Robust